Tag Archives: Novartis’s

Senator Grassley seeks info on Novartis’s Zolgensma data issues

FILE PHOTO: U.S. Senator Chuck Grassley (R-IA) speaks to reporters on his way from the Senate floor after a vote at the U.S. Capitol in Washington, U.S. May 14, 2019. REUTERS/Jonathan Ernst/File Photo (Reuters) – U.S. Senate Finance Committee Chairman Chuck Grassley has asked Swiss drugmaker Novartis AG to provide details on data manipulation related… Read More »